Back to Nephrology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Lupus Nephritis

Overview

Spherix’s coverage of the lupus nephritis market combines insights from nephrologists and rheumatologists to provide coverage on both current, as well as evolving, treatment paradigms, as patients with high unmet needs begin to see new solutions. Market trending reports coupled with patient chart audits and launch trackers for exciting new products provide unique and invaluable insights into this expanding market.

Services Available

Exploring the patient journey

  • Lupus Nephritis (US) - n=1,000 patient charts

Prepping for the pipeline

  • Lupus Nephritis (US) - n=100 patient charts

Benchmarking new brand performance

  • Benlysta (GSK) and Lupkynis (Aurinia) in Lupus Nephritis (US)

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Lupus Nephritis Coverage